Annual versus less frequent mammographic surveillance in people with breast cancer aged 50 years and older in the UK (Mammo-50): cost-effectiveness and budget impact analysis
Less frequent mammogram surveillance is cost-effective. Uncertainty remains due to variability in costs and quality of life estimates, and missing data in the less frequent arm due to study design. Given the trial's non-inferiority findings, this strategy is recommended from healthcare and societal perspectives.
Authors
- Claire Hulme (ORCID: https://orcid.org/0000-0003-2077-0419)
- Janet Dunn (ORCID: https://orcid.org/0000-0001-7313-4446)
- Peter S Hall (ORCID: https://orcid.org/0000-0001-6015-7841)
- Chris Bojke (ORCID: https://orcid.org/0000-0003-2601-0314)
- Paola Cocco (ORCID: https://orcid.org/0000-0002-0652-6877)
- Ashley M. Hopkins (ORCID: https://orcid.org/0000-0001-7652-4378)
- Bethany Shinkins (ORCID: https://orcid.org/0000-0001-5350-1018)
- David Meads (ORCID: https://orcid.org/0000-0003-1369-2483)
- Andrea Marshall
Institutions
- University of Leeds (GB)
- University of Exeter (GB)
- University of Warwick (GB)
- University of Edinburgh (GB)
Publication Details
- Journal
- British Journal of Cancer
- Published
- 2025-11-06
- DOI
- https://doi.org/10.1038/s41416-025-03248-2
- Primary Topic
- Global Cancer Incidence and Screening
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Institute for Health and Care Research
- University of Warwick
- University of Leeds